Table 1.
Clinicopathologic characteristics | High expression (%) | Low expression (%) | X2 | P |
---|---|---|---|---|
Age | 0.122 | 0.726 | ||
≤ 60 | 18 (81.8) | 10 (76.9) | ||
> 60 | 4 (18.2) | 3 (23.1) | ||
Tumor size | 1.301 | 0.522 | ||
< 2 cm | 10 (45.5) | 7 (53.8) | ||
2-5 cm | 10 (45.5) | 6 (46.2) | ||
> 5 cm | 2 (9) | 0 (0) | ||
Lymph node metastasis | 4.609 | 0.032* | ||
NO | 7 (31.8) | 9 (69.2) | ||
YES | 15 (68.2) | 4 (30.8) | ||
Clinical stage | 6.655 | 0.010* | ||
I-II | 7 (31.8) | 10 (76.9) | ||
III-IV | 15 (68.2) | 3 (23.1) | ||
Estrogen receptor | 0.530 | 0.467 | ||
Negative | 8 (36.3) | 5 (50) | ||
Positive | 14 (63.6) | 5 (50) | ||
Progesterone receptor | 0.057 | 0.811 | ||
Negative | 10 (45.5) | 5 (50) | ||
Positive | 12 (54.5) | 5 (50) |
P < 0.05.